(Q34286861)

1 August 2017

Poly(ADP-ribose) reactivates stalled DNA topoisomerase I and Induces DNA strand break resealing (English)

1 reference

1 August 2017

Maria Malanga

1

1 reference

PubMed ID

14699148

1 August 2017

Felix R Althaus

series ordinal

2

1 reference

PubMed ID

14699148

1 August 2017

language of work or name

English

0 references

publication date

29 December 2003

1 reference

Journal of Biological Chemistry

1 August 2017

1 reference

1 August 2017

279

1 reference

1 August 2017

5244-5248

1 reference

1 August 2017

7

1 reference

Cellular roles of dna topoisomerases: a molecular perspective

1 August 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Topological challenges to DNA replication: conformations at the fork

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Topoisomerase I-mediated DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Tumor cell death induced by topoisomerase-targeting drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

DNA single-strand break repair and spinocerebellar ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Comparative characterisation of poly(ADP-ribose) polymerase-1 from two mammalian species with different life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Poly(ADP-ribose) quantification at the femtomole level in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

High resolution size analysis of ADP-ribose polymers using modified DNA sequencing gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

A functional linker in human topoisomerase I is required for maximum sensitivity to camptothecin in a DNA relaxation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

A human topoisomerase I cleavage complex is recognized by an additional human topisomerase I molecule in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Spatial and temporal cellular responses to single-strand breaks in human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

A proteomic approach to the identification of heterogeneous nuclear ribonucleoproteins as a new family of poly(ADP-ribose)-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Poly(ADP-ribose) binds to specific domains of p53 and alters its DNA binding functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

A model for the mechanism of human topoisomerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Reconstitution of enzymatic activity by the association of the cap and catalytic domains of human topoisomerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

Expression of human topoisomerase I with a partial deletion of the linker region yields monomeric and dimeric enzymes that respond differently to camptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C300437200

21 January 2018

Identifiers

DOI

10.1074/JBC.C300437200

1 reference

1 August 2017

1 reference

PubMed ID

14699148